MLYS · Mineralys Therapeutics, Inc. · Documents
$21.54
+0.07 (+0.33%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$1.90B
Shares
88.41M
Volume · Oct 22
824.73K
Avg daily vol (3M)
1.13M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Mineralys Therapeutics appointed Kristine Peterson and Lonnel Coats to its Board effective October 19, 2026, raising Board size from seven to nine directors. Each received options for 16,600 shares and RSUs covering 12,400 shares vesting over three years. | 2026-10-19 | 2026-10-16 | |
| Investor Event Transcript | — | 2026-09-09 | 2026-09-30 | |
| 8-K | — | 2026-08-11 | 2026-08-05 | |
| 10-Q | — | 2026-08-11 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-06-09 | 2026-06-30 | |
| 8-K | — | 2026-06-03 | 2026-06-02 | |
| 8-K | — | 2026-06-03 | — | |
| Investor Event Transcript | — | 2026-06-03 | 2026-06-30 | |
| 8-K | — | 2026-05-22 | 2026-05-21 | |
| Investor Event Transcript | — | 2026-05-21 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-12 | 2026-06-30 | |
| 10-Q | — | 2026-05-06 | 2026-03-31 | |
| 8-K | — | 2026-05-06 | — | |
| ARS | — | 2026-04-10 | 2025-12-31 | |
| DEFA14A | — | 2026-04-08 | — | |
| DEF 14A | — | 2026-04-08 | 2026-05-21 | |
| 8-K | — | 2026-03-12 | — | |
| 10-K | — | 2026-03-12 | 2025-12-31 | |
| 8-K | — | 2026-03-09 | 2026-03-06 | |
| 8-K | — | 2026-01-06 | — | |
| 10-Q | — | 2025-11-10 | 2025-09-30 | |
| 8-K | — | 2025-11-10 | — | |
| S-3ASR | — | 2025-11-10 | — | |
| 8-K | — | 2025-09-03 | 2025-09-02 | |
| 8-K | — | 2025-09-02 | — | |
| 8-K | — | 2025-08-12 | — | |
| 10-Q | — | 2025-08-12 | 2025-06-30 | |
| 8-K | — | 2025-06-17 | — | |
| 8-K | — | 2025-05-22 | — | |
| 10-Q | — | 2025-05-12 | 2025-03-31 | |
| 8-K | — | 2025-05-12 | — | |
| ARS | — | 2025-04-09 | 2024-12-31 | |
| DEF 14A | — | 2025-04-09 | 2025-05-22 | |
| DEFA14A | — | 2025-04-09 | — | |
| 8-K | — | 2025-03-31 | 2025-03-29 | |
| 8-K | — | 2025-03-12 | 2025-03-11 | |
| 8-K | — | 2025-03-10 | — | |
| 8-K | — | 2025-02-12 | — | |
| 10-K | — | 2025-02-12 | 2024-12-31 | |
| 8-K | — | 2025-02-04 | — | |
| 8-K | — | 2025-01-08 | — | |
| 8-K | — | 2024-11-12 | 2024-11-11 | |
| 10-Q | — | 2024-11-12 | 2024-09-30 | |
| 8-K | — | 2024-10-30 | — | |
| 8-K | — | 2024-09-25 | — | |
| 10-Q | — | 2024-08-13 | 2024-06-30 | |
| 8-K | — | 2024-08-13 | — | |
| 8-K | — | 2024-06-14 | 2024-06-13 | |
| 8-K | — | 2024-06-10 | — | |
| 8-K | — | 2024-05-31 | — |
Showing 1–50 of 81 filings
Key facts
CIK
1933414
CUSIP
603170101
13F (30d)
17 filings
17 filers
Visit website
Investor relations